HCPLive

Breakthrough Pain 
The MD Magazine Breakthrough Pain condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

J. Michael Bostwick from Mayo Clinic: Are Cannabinoids a Viable Treatment Option for Neuropathic Pain
As more states across the country legalize marijuana in a variety of forms the usefulness of cannabinoids as a treatment method for people with neuropathic pain remains a question that many studies have explored.
As patients seek help for chronic and acute pain problems doctors and health care professionals continue to seek new treatment options beyond surgery and medication.
With a continually growing opioid addiction new guidelines have been adopted looking to help fight this problem across the population. Some concerns have been raised about whether this will cause doctors to shy away from prescribing the medications for patients who can benefit most from them.
Temple University Researchers suggest that a guideline created by Temple University Hospital and Temple University Hospital-Episcopal Campus for prescribing opioids in order to maximize safety and avoid misuse appears to significantly decrease the rate of opioid prescribing for minor and chronic non-cancer pain complaints in an acute care setting.
Recently published reports show the immune system of spinal cord patients can be controlled using a family of therapeutic stem cells.
Electrostimulation is becoming a growing trend in medicine as researchers find new ways to help patients better manage their pain symptoms.
Readmissions are a concern and a dilemma for hospitals across the nation as the federal government docks facilities when patients are readmitted within 30 days of discharge. It has caused a surge in research about the causes of readmission and strategies to avoid them.
The number of opioid-related deaths nearly quadrupled from 1999 to 2011 in the US; and while that number continues to increase, one state has made positive strides with the implementation of two initiatives.
With 259 million painkiller prescriptions written in 2012 alone, according to the Centers for Disease Control and Prevention (CDC), one of the most common side effects experienced by patients being treated for chronic pain is opioid-induced constipation (OIC).

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$